Teva Announces Patient Characteristic Data from the Therapy Optimization in Multiple Sclerosis

Stuart SchlossmanMS Research Study and Reports


Largest Prospective Phase IV Study in MS will Evaluate Adherence, Outcomes of Patients in Specialty Pharmacy Medication Therapy Management Programs
KANSAS CITY, Mo.–(BUSINESS WIRE)– Teva Neuroscience today announced baseline patient characteristics from the fully enrolled Therapy Optimization in Multiple Sclerosis (TOP MS) study. TOP MS represents the largest prospective Phase IV study conducted in MS, and these data characterize the MS population receiving treatment and medication therapy management (MTM) via specialty pharmacy programs. The study results, anticipated in late 2012, will provide insight into the benefits of adherence to therapy on MS patients’ health outcomes.
“These data provide an overview of the baseline characteristics of the contemporary MS patient populations, which have evolved dramatically over the past twenty years,” saidMerriKay Oleen-Burkey, PhD, principal investigator of the TOP MS study. “Many specialty pharmacies have reinforced their commitment to MS patients by implementing MTM programs. TOP MS will examine the addition of self-reported patient outcomes to MTM programs, with the goal of providing insight into the benefits of adherence to therapy on MS patients’ health outcomes.”
Of the 2,901 participants who have completed surveys, initial self-reported patient characteristic data from TOP MS include: 

**************************************************************** 

Know somebody affected by Multiple Sclerosis?
Ask them to remain CURRENT with Multiple Sclerosis news & information 
 when registered at the  MS Views and News  website
.Weekly e-Newsletter now reaching (85) Countries. .
***************************************************************************************
Help STUART  to Educate:  Please donate   
– all contributions are tax deductible – 
We are a 501c3 – Not for Profit Charity
.
“Providing You with ‘MS Views and News’, is what we do“
***************************************************************************************
.
Disclaimer:  ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews